A. Jambrecina

Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine

F. Müller, M. Fromm, K. Hohl, 2020, Clinical Pharmacokinetics.

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

M. Addo, A. Lohse, G. Sutter, 2020, The Lancet Infectious Diseases.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.

M. Altfeld, S. Yerly, M. Addo, 2016, The New England journal of medicine.

Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.

D. Jung, E. Schwedhelm, R. Maas, 2008, British journal of clinical pharmacology.

Comparison of In Vitro and In Vivo Percutaneous Absorption Across Human Skin Using BAY1003803 Formulated as Ointment and Cream

R. Nave, A. Jambrecina, F. Toner, 2019, Clinical pharmacology in drug development.

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.

M. Saville, Stéphanie Pépin, A. Jambrecina, 2013, Vaccine.

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

A. Schaefer, Shinn-Jang Hwang, G. Icardi, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment of Oropharyngeal Symptoms: A Prospective, Single-Dose, Placebo-Controlled, Randomized Clinical Trial

Lilli Gerstenmaier, G. Bleckert, D. Wilhelm, 2022, Open Access Journal of Clinical Trials.

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization☆

M. Addo, M. Kieny, S. Agnandji, 2017, EBioMedicine.

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Hyo Youl Kim, Kenjiro Nakamura, A. Schaefer, 2022, Open forum infectious diseases.

Midazolam microdosing applied in early clinical development for drug–drug interaction assessment

G. Mikus, M. Goettel, S. Wiebe, 2020, British journal of clinical pharmacology.